NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences Inc. is headquartered in Vancouver, Canada.…
Nanosphere Health Sciences (CNSX: NSHS) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.
The shares were at 0.0250 CAD on 16 November 2026, down 16.7% over 52 weeks. Its 52-week range is 0.0200 CAD to 0.0350 CAD: the price is 28.6% below the high and 25.0% above the low.
Its market capitalisation is 205.50K CAD.
Nanosphere Health Sciences reports return on equity of 6.3% and an operating margin of 0.0%.
Its debt exceeds its cash by 75.75K USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.
No upcoming events tracked.